EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H36N6O5S |
| Net Charge | 0 |
| Average Mass | 532.667 |
| Monoisotopic Mass | 532.24679 |
| SMILES | [H][C@@]12COC(=N1)[C@H](C(C)C)NC(=O)[C@@]1([H])N=C(O[C@@H]1C)[C@H](C(C)C)NC(=O)c1csc(n1)[C@H](C(C)C)NC2=O |
| InChI | InChI=1S/C25H36N6O5S/c1-10(2)16-23-26-14(8-35-23)20(32)30-18(12(5)6)25-27-15(9-37-25)21(33)28-17(11(3)4)24-31-19(13(7)36-24)22(34)29-16/h9-14,16-19H,8H2,1-7H3,(H,28,33)(H,29,34)(H,30,32)/t13-,14+,16+,17+,18+,19+/m1/s1 |
| InChIKey | PVKWKGXPRJQDIZ-XZHCTYTHSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Lissoclinum bistratum (ncbitaxon:322849) | - | PubMed (12608858) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bistratamide F (CHEBI:65505) has role antineoplastic agent (CHEBI:35610) |
| bistratamide F (CHEBI:65505) has role metabolite (CHEBI:25212) |
| bistratamide F (CHEBI:65505) is a homodetic cyclic peptide (CHEBI:24613) |
| bistratamide F (CHEBI:65505) is a macrocycle (CHEBI:51026) |
| IUPAC Name |
|---|
| (4S,7R,8S,11S,15S,18S)-7-methyl-4,11,18-tri(propan-2-yl)-6,13-dioxa-20-thia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.15,8.112,15]tetracosa-1(21),5(24),12(23),19(22)-tetraene-2,9,16-trione |
| Manual Xrefs | Databases |
|---|---|
| 9235654 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| Reaxys:9453053 | Reaxys |
| Citations |
|---|